3,4-dihydroxyphenylacetic acid and pnu-282987

3,4-dihydroxyphenylacetic acid has been researched along with pnu-282987 in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Alvarez-Fischer, D; Bacher, M; Balzer-Geldsetzer, M; Dodel, RC; Noelker, C; Oertel, WH; Stuckenholz, V1

Other Studies

1 other study(ies) available for 3,4-dihydroxyphenylacetic acid and pnu-282987

ArticleYear
The α7 nAChR agonist PNU-282987 reduces inflammation and MPTP-induced nigral dopaminergic cell loss in mice.
    Journal of Parkinson's disease, 2013, Volume: 3, Issue:2

    Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Benzamides; Bridged Bicyclo Compounds; Calcium-Binding Proteins; Chromatography, High Pressure Liquid; Corpus Striatum; Cytokines; Dopamine; Dopaminergic Neurons; Encephalitis; Enzyme-Linked Immunosorbent Assay; Homovanillic Acid; Male; Mecamylamine; Mice; Mice, Inbred C57BL; Microfilament Proteins; Nicotinic Agonists; Parkinsonian Disorders

2013